Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA
Authors:
- W.U. ShipleyWSW.U. Shipley
- W. SeiferheldWSW. Seiferheld
- H. LukkaHLH. Lukka
- P. MajorPMP. Major
- N.M. HeneyNHN.M. Heney
- D. GrignonDGD. Grignon
- O. SartorOSO. Sartor
- M. PatelMPM. Patel
- J.P. BaharyJBJ.P. Bahary
- A.L. ZietmanAZA.L. Zietman
- T.M. PisanskyTPT.M. Pisansky
- K.L. ZeitzerKZK.L. Zeitzer
- 1 January 2016
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 94 (1) , 3